GALMED PHARMACEUTICALS LTD.

GLMD ·Healthcare, Drug Manufacturers - General, Israel
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SC 13G Sep 20, 2024
6-K Sep 19, 2024
6-K Sep 16, 2024
EFFECT Sep 9, 2024
424B3 Sep 9, 2024
UPLOAD Sep 9, 2024
CORRESP Sep 9, 2024
F-1 Aug 30, 2024
6-K Aug 30, 2024
6-K Aug 28, 2024
6-K Aug 27, 2024
6-K Jul 18, 2024
6-K Jul 11, 2024
6-K Jun 5, 2024
6-K May 30, 2024
20-F Apr 4, 2024
6-K Mar 19, 2024
6-K Mar 15, 2024
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G/A Feb 14, 2024 AMENDMENT NO. 5 TO SCHEDULE 13G
SC 13G/A Feb 12, 2024
EFFECT Nov 29, 2023
POS AM Nov 22, 2023
6-K Nov 22, 2023
6-K Nov 20, 2023
← Newer Page 5 of 16 · 381 filings Older →